Adolescence is the starting point of sex-dichotomous COMT genetic effects

被引:25
|
作者
Sannino, S. [1 ]
Padula, M. C. [2 ]
Manago, F. [1 ]
Schaer, M. [2 ]
Schneider, M. [2 ]
Armando, M. [3 ]
Scariati, E. [2 ]
Sloan-Bena, F. [4 ]
Mereu, M. [1 ,5 ]
Pontillo, M. [3 ]
Vicari, S. [3 ]
Contarini, G. [5 ]
Chiabrera, C. [1 ]
Pagani, M. [6 ,7 ]
Gozzi, A. [6 ]
Eliez, S. [2 ]
Papaleo, F. [1 ]
机构
[1] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Via Morego 30, I-16163 Genoa, Italy
[2] Univ Geneva, Dept Psychiat, Off Med Pedag, Geneva, Switzerland
[3] Bambino Gesu Pediat Hosp, Dept Neurosci, Piazza St Onofrio, Rome, Italy
[4] Univ Geneva Hosp, Serv Genet Med, Geneva, Switzerland
[5] Univ Padua, Dipartimento Sci Farmaco, Padua, Italy
[6] Ist Italiano Tecnol, Ctr Neurosci & Cognit Syst, Funct Neuroimaging Lab, Rovereto, Italy
[7] Univ Trento, Ctr Mind & Brain Sci, Rovereto, Italy
来源
基金
瑞士国家科学基金会;
关键词
22Q11.2 DELETION SYNDROME; CATECHOL-O-METHYLTRANSFERASE; CARDIO-FACIAL SYNDROME; DORSOLATERAL PREFRONTAL CORTEX; CHROMOSOME; 22Q11.2; VELOCARDIOFACIAL SYNDROME; DOPAMINE SYNTHESIS; COGNITIVE FUNCTION; IN-VIVO; PSYCHIATRIC-DISORDERS;
D O I
10.1038/tp.2017.109
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The catechol-o-methyltransferase (COMT) genetic variations produce pleiotropic behavioral/neuroanatomical effects. Some of these effects may vary among sexes. However, the developmental trajectories of COMT-by-sex interactions are unclear. Here we found that extreme COMT reduction, in both humans (22q11.2 deletion syndrome COMT Met) and mice (COMT -/-), was associated to cortical thinning only after puberty and only in females. Molecular biomarkers, such as tyrosine hydroxylase, Akt and neuronal/cellular counting, confirmed that COMT-by-sex divergent effects started to appear at the cortical level during puberty. These biochemical differences were absent in infancy. Finally, developmental cognitive assessment in 22q11DS and COMT knockout mice established that COMT-by-sex-dichotomous effects in executive functions were already apparent in adolescence. These findings uncover that genetic variations severely reducing COMT result in detrimental cortical and cognitive development selectively in females after their sexual maturity. This highlights the importance of taking into account the combined effect of genetics, sex and developmental stage.
引用
收藏
页码:e1141 / e1141
页数:12
相关论文
共 50 条
  • [1] Adolescence is the starting point of sex-dichotomous COMT genetic effects
    S Sannino
    M C Padula
    F Managò
    M Schaer
    M Schneider
    M Armando
    E Scariati
    F Sloan-Bena
    M Mereu
    M Pontillo
    S Vicari
    G Contarini
    C Chiabrera
    M Pagani
    A Gozzi
    S Eliez
    F Papaleo
    Translational Psychiatry, 2017, 7 : e1141 - e1141
  • [2] Sex-dichotomous effects of functional COMT genetic variations on cognitive functions disappear after menopause in both health and schizophrenia
    Papaleo, Francesco
    Sannino, Sara
    Piras, Fabrizio
    Spalletta, Gianfranco
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (12) : 2349 - 2363
  • [3] Sex Differences in COMT Polymorphism Effects on Prefrontal Inhibitory Control in Adolescence
    Thomas P White
    Eva Loth
    Katya Rubia
    Lydia Krabbendam
    Robert Whelan
    Tobias Banaschewski
    Gareth J Barker
    Arun LW Bokde
    Christian Büchel
    Patricia Conrod
    Mira Fauth-Bühler
    Herta Flor
    Vincent Frouin
    Jürgen Gallinat
    Hugh Garavan
    Penny Gowland
    Andreas Heinz
    Bernd Ittermann
    Claire Lawrence
    Karl Mann
    Marie-Laure Paillère
    Frauke Nees
    Tomas Paus
    Zdenka Pausova
    Marcella Rietschel
    Trevor Robbins
    Michael N Smolka
    Sukhwinder S Shergill
    Gunter Schumann
    Neuropsychopharmacology, 2014, 39 : 2560 - 2569
  • [4] Sex Differences in COMT Polymorphism Effects on Prefrontal Inhibitory Control in Adolescence
    White, Thomas P.
    Loth, Eva
    Rubia, Katya
    Krabbendam, Lydia
    Whelan, Robert
    Banaschewski, Tobias
    Barker, Gareth J.
    Bokde, Arun L. W.
    Buechel, Christian
    Conrod, Patricia
    Fauth-Buehler, Mira
    Flor, Herta
    Frouin, Vincent
    Gallinat, Jugen
    Garavan, Hugh
    Gowland, Penny
    Heinz, Andreas
    Ittermann, Bernd
    Lawrence, Claire
    Mann, Karl
    Paillere, Marie-Laure
    Nees, Frauke
    Paus, Tomas
    Pausova, Zdenka
    Rietschel, Marcella
    Robbins, Trevor
    Smolka, Michael N.
    Shergill, Sukhwinder S.
    Schumann, Gunter
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 (11) : 2560 - 2569
  • [5] Sex-dichotomous effects of NOS1AP promoter DNA methylation on intracranial aneurysm and brain arteriovenous malformation
    Wang, Zhepei
    Zhao, Jikuang
    Sun, Jie
    Nie, Sheng
    Li, Keqing
    Gao, Feng
    Zhang, Tiefeng
    Duan, Shiwei
    Di, Yazhen
    Huang, Yi
    Gao, Xiang
    NEUROSCIENCE LETTERS, 2016, 621 : 47 - 53
  • [6] Pain modality- and sex-specific effects of COMT genetic functional variants
    Belfer, Inna
    Segall, Samantha K.
    Lariviere, William R.
    Smith, Shad B.
    Dai, Feng
    Slade, Gary D.
    Rashid, Naim U.
    Mogil, Jeffrey S.
    Campbell, Claudia M.
    Edwards, Robert R.
    Liu, Qian
    Bair, Eric
    Maixner, William
    Diatchenko, Luda
    PAIN, 2013, 154 (08) : 1368 - 1376
  • [7] Starting point bias in dichotomous choice valuation with follow-up questioning
    Herriges, JA
    Shogren, JF
    JOURNAL OF ENVIRONMENTAL ECONOMICS AND MANAGEMENT, 1996, 30 (01) : 112 - 131
  • [8] Starting point bias and respondent uncertainty in dichotomous choice contingent valuation surveys
    Flachaire, Emmanuel
    Hollard, Guillaume
    RESOURCE AND ENERGY ECONOMICS, 2007, 29 (03) : 183 - 194
  • [9] Sex effects for the interaction of dopamine related genetic variants for COMT and BDNF on declarative memory performance
    Van der Auwera, Sandra
    Terock, Jan
    Teumer, Alexander
    Schomerus, Georg
    Homuth, Georg
    Grabe, Hans J.
    GENES BRAIN AND BEHAVIOR, 2021, 20 (05)
  • [10] Janus Molecule I: Dichotomous Effects of COMT in Neuropathic vs Nociceptive Pain Modalities
    Segall, S. K.
    Maixner, W.
    Belfer, I.
    Wiltshire, T.
    Seltzer, Z.
    Diatchenko, L.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (03) : 222 - 235